Active	Status	Sponsor type	Region	Phase	Filter
12 Active 6 Inactive 18 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Miller, Jennifer
NCT06046820: The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency	Recruiting	3	33	Europe, Canada, US, RoW	INZ-701, (rhENPP1-Fc)., Control Arm (Conventional Therapy)	Inozyme Pharma	Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial Calcification of Infancy	05/25	06/25
NCT05035927: Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating Disorder	Active, not recruiting	2a	10	US	TRYP-0082, Psilocybin, Psychotherapy	TRYP Therapeutics	Binge Eating Disorder	06/24	08/25
NCT04301843: Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma	Recruiting	2	131	Canada, US	Eflornithine, DFMO, difluoromethylornithine	Giselle Sholler, K C Pharmaceuticals Inc., Beat NB Cancer Foundation, Team Parker for Life	Neuroblastoma	10/28	10/33
PEDS-PLAN, NCT02559778: Pediatric Precision Laboratory Advanced Neuroblastoma Therapy	Recruiting	2	500	Canada, US	Ceritinib, Zykadia, dasatinib, Sprycel, sorafenib, Nexavar, vorinostat, ZOLINZA, DFMO, Eflornithine, α-difluoromethylornithine	Giselle Sholler, Dell, Inc., Beat NB Cancer Foundation, K C Pharmaceuticals Inc., Team Parker for Life	Neuroblastoma	09/30	09/35
Patel, Manisha J
No trials found
Mena, Fernando
No trials found
Yu, Jenny
No trials found